PND116 - A THREE MONTH INTERIM ANALYSIS OF FINGOLIMOD TREATMENT ADHERENCE FOR RELAPSING REMITTING MULTIPLE SCLEROSIS IN THE UK: THE PATIENT REPORTED OUTCOMES WITH FINGOLIMOD IN LOCAL EXPERIENCE (PROFILE) STUDY

Autor: Adlard, NE, Watson, J, Bottomley, CJ, Kroes, M

Publikováno v: In Value in Health October 2018 21 Supplement 3:S348-S348

PCN234 - Work Productivity in HER2 Positive Breast Cancer: A Comparison of Patients Across Stages of Early and Metastatic Disease

Autor: Verrill, M, Schmid, P, Retzler, J, Smith, AB, Bottomley, CJ, Dando, S, Tran, I, Leslie, I, Wardley, A

Publikováno v: In Value in Health October-November 2017 20(9):A454-A454

PMS97 - A Multi-Centre Retrospective Study To Describe The Impact on Healthcare Resource Use And Real World Effectiveness of Golimumab In Ankylosing Spondylitis (AS) In UK Clinical Practice

Autor: Gaffney, K, Dunkley, L, Goodson, N, Kerrigan, S, Marshall, D, Savanovic-Abel, O, Sengupta, R, Mackay, C, Tsoumani, E, McCann, E, Futter, T, Hickey, J, Bottomley, CJ

Publikováno v: In Value in Health October-November 2017 20(9):A543-A543

PND73 Using A Mixed Methods Approach to Develop A Discrete Choice Experiment In Multiple Sclerosis

Autor: Padania, S, Bottomley, CJ, Adlard, N, Watson, J, Lloyd, AJ

Publikováno v: Value in Health. (7):A761

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::f54b148839c7e309800149711542b777

Validation of the German version of the Family Reported Outcome Measure (FROM-16) to assess the impact of disease on the partner or family member.

Autor: Elsner SA; Institute for Social Medicine and Epidemiology, University of Luebeck, Ratzeburger Allee 160, 23562, Luebeck, Germany. susanne.elsner@uksh.de., Salek SS; School of Life and Medical Sciences, University of Hertfordshire, Hatfield, AL10 9AB, UK.; Outcomes Research, Institute for Medicines Development, Cardiff, CF23 6NP, UK., Finlay AY; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, CF14 4XN, UK., Hagemeier A; Institute for Social Medicine and Epidemiology, University of Luebeck, Ratzeburger Allee 160, 23562, Luebeck, Germany., Bottomley CJ; Vitaccess, Centre for Innovation, New Road, Oxford, OX1 1BY, UK., Katalinic A; Institute for Social Medicine and Epidemiology, University of Luebeck, Ratzeburger Allee 160, 23562, Luebeck, Germany.; Cancer Registry Schleswig-Holstein, University of Luebeck, Luebeck, Germany., Waldmann A; Institute for Social Medicine and Epidemiology, University of Luebeck, Ratzeburger Allee 160, 23562, Luebeck, Germany.

Publikováno v: Health and quality of life outcomes [Health Qual Life Outcomes] 2021 Mar 24; Vol. 19 (1), pp. 106. Date of Electronic Publication: 2021 Mar 24.